Description: Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs. The company also develops organ-derived biological products for various applications, such as soft tissue reinforcement and wound care. It uses its perfusion decellularization/recellularization technology to engineer transplantable organs for the people who need them. Miromatrix Medical Inc. has strategical partnerships with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. Miromatrix Medical Inc. was formerly known as TayTech, Inc. The company was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
Home Page: www.miromatrix.com
MIRO Technical Analysis
6455 Flying Cloud Drive
Eden Prairie,
MN
55344
United States
Phone:
952 942 6000
Officers
| Name | Title |
|---|---|
| Dr. Jeffrey James Ross Ph.D. | CEO & Director |
| Mr. Brian D. Niebur CPA | CFO & VP of Fin. |
| Mr. James M. Douglas | CFO & Sec. |
| Mr. Tom Emig | VP of People & Culture |
| Dr. John Joseph Barry Ph.D. | VP of R&D |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.6176 |
| Price-to-Sales TTM: | 1921.4622 |
| IPO Date: | 2021-06-24 |
| Fiscal Year End: | December |
| Full Time Employees: | 61 |